Over 30 million psychedelic users in the United States [v1; ref status: indexed, http://f1000r.es/w8]

Over 30 million psychedelic users in the United States [v1; ref status: indexed, http://f1000r.es/w8]

We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychede...

Full description

Bibliographic Details
Main Authors: Teri S Krebs, Pål-Ørjan Johansen
Format: Article
Language:English
Published: F1000 Research Ltd 2013-03-01
Series:F1000Research
Subjects:
Epidemiology
Social & Behavioral Determinants of Health
Online Access:http://f1000research.com/articles/2-98/v1
id doaj-971dba8f137a472eb4abd38e77069f84
record_format Article
spelling doaj-971dba8f137a472eb4abd38e77069f842020-11-25T03:47:26ZengF1000 Research LtdF1000Research2046-14022013-03-01210.12688/f1000research.2-98.v11160Over 30 million psychedelic users in the United States [v1; ref status: indexed, http://f1000r.es/w8]Teri S Krebs0Pål-Ørjan Johansen1Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, NorwayDepartment of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, NorwayWe estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychedelic users in the US in 2010; including 17% of people aged 21 to 64 years (22% of males and 12% of females). Rate of lifetime psychedelic use was greatest among people aged 30 to 34 (total 20%, including 26% of males and 15% of females).http://f1000research.com/articles/2-98/v1EpidemiologySocial & Behavioral Determinants of Health
collection DOAJ
language English
format Article
sources DOAJ
author Teri S Krebs
Pål-Ørjan Johansen
spellingShingle Teri S Krebs
Pål-Ørjan Johansen
Over 30 million psychedelic users in the United States [v1; ref status: indexed, http://f1000r.es/w8]
F1000Research
Epidemiology
Social & Behavioral Determinants of Health
author_facet Teri S Krebs
Pål-Ørjan Johansen
author_sort Teri S Krebs
title Over 30 million psychedelic users in the United States [v1; ref status: indexed, http://f1000r.es/w8]
title_short Over 30 million psychedelic users in the United States [v1; ref status: indexed, http://f1000r.es/w8]
title_full Over 30 million psychedelic users in the United States [v1; ref status: indexed, http://f1000r.es/w8]
title_fullStr Over 30 million psychedelic users in the United States [v1; ref status: indexed, http://f1000r.es/w8]
title_full_unstemmed Over 30 million psychedelic users in the United States [v1; ref status: indexed, http://f1000r.es/w8]
title_sort over 30 million psychedelic users in the united states [v1; ref status: indexed, http://f1000r.es/w8]
publisher F1000 Research Ltd
series F1000Research
issn 2046-1402
publishDate 2013-03-01
description We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychedelic users in the US in 2010; including 17% of people aged 21 to 64 years (22% of males and 12% of females). Rate of lifetime psychedelic use was greatest among people aged 30 to 34 (total 20%, including 26% of males and 15% of females).
topic Epidemiology
Social & Behavioral Determinants of Health
url http://f1000research.com/articles/2-98/v1
work_keys_str_mv AT teriskrebs over30millionpsychedelicusersintheunitedstatesv1refstatusindexedhttpf1000resw8
AT palørjanjohansen over30millionpsychedelicusersintheunitedstatesv1refstatusindexedhttpf1000resw8
_version_ 1724501842701844480

Similar Items